IASIS PHARMA and its subsidiary company Pharma Q, Chios Mastiha Growers Association and its subsidiary Mediterra, and Pharmagnose, the spin-off company of the Faculty of Pharmacy - University of Athens, join forces setting Greek nature as a focal point, by establishing the unique Chios Mastiha Research & Development Center. Manufactured with pharmaceutical industry standards, the [...]
Always committed to continuous growth, IASIS PHARMA purchased at 2016 a 45.000m2 property in Attica, in order to construct new, larger and more efficient facilities. The new property will combine 3 Dedicated and Separated Production Facilities, Research & Development Center, administrative offices and 2.500m2 state-of-the-art Warehousing facilities. The new Production Facilities are planned in compliance [...]
Vari’s Elderly Care Unit, Attica 13-14/06/2017 IASIS PHARMA, always loyal to its social corporate responsibility and support to medical experts and patients, cooperated with the Greek association for skeletal health “Petalouda” (Petalouda stands for Butterfly in Greek), carrying out an event to inform people about preventing and confronting osteoporosis. The event was carried out at [...]
The first meeting of the research program under the distinct title “EXANDAS” of the Marie Sklodowska Curie Actions (MSCA) program successfully took place on 21-22 April 2017. The program aims to exploit the aromatic plants’ by-products, Chios Mastic included, for the purpose of developing novel pharmaceutical products. The program’s coordinator is Assistant Prof. N. Aligiannis, [...]
Perama, Attica 30-31/03/2017 IASIS PHARMA, always showing true interest for its social corporate responsibility and support to medical experts and patients, cooperated for once more with the Greek association for skeletal health “Petalouda” (the Greek word for Butterfly), carrying out an event to inform people about various skeletal health subjects and osteoporosis. The event was carried [...]
MAKEDONIA PALACE HOTEL, THESSALONIKI, 6-8/4/2017 ΙΑSIS PHARMA showed its active interest for the Field of Cardiology, by participating in the 17th Panhellenic Hypertension Conference . The conference was organized by the Hellenic Hypertension Society (Ε.Υ.Υ) and took place at Makedonia Palace Hotel, from April 6th to 8th, in Thessaloniki, Macedonia. The event was addressed to [...]
ATHENS CONCERT HALL, ATHENS, 08/04/2017 ΙΑSIS PHARMA, proving its active involvement in Dermatology, participated for another consecutive year in the Annual Spring Day Conference of the Hellenic Society of Dermatology and Venereology, that took place at Athens Concert Hall, April 8th 2017. The event was carried out under the title: “Skin in delicate ages”. ΙΑSIS [...]
PHYSIOLOGY AMPHITHEATER, ATHENS MEDICAL SCHOOL, GOUDI, 31/03 – 1/04/2017 For one more successive year, IASIS PHARMA participated as a Main Sponsor in the 22nd Greek Conference for Helicobacter pylori and Other Infections of the Digestive Tract. The conference was organized by the Greek Society for the Study of H. pylori (E.E.M.E.P.), took place at Athens [...]
Neo Iraklio, Attica, 27-28/03/2017 IASIS PHARMA, keeping up its social corporate responsibility and support to medical experts and patients, cooperated with the Greek association for skeletal health “Petalouda” (Petalouda is the Greek word for Butterfly), carrying out an event to inform people about various skeletal health subjects and osteoporosis. The event was carried out in [...]
IASIS PHARMA announces the launch of the original antihypertensive pharmaceutical product under the brand name of Rami-Amlo®. The product is a fixed-dose combination of an Angiotensin Converting Enzyme (ACE) Inhibitor with a Calcium Channel Blocker. Each Rami-Amlo® capsule, contains the active ingredients Ramipril & Amlodipine, combined in a single dosage form, in 4 strengths: 5mg [...]
